Calidi Biotherapeutics (CLDI) Shares Outstanding (Entity) (2021 - 2026)
Calidi Biotherapeutics' Shares Outstanding (Entity) came in at 1.42 million for Q2 2026, up 687.5% from 179,812 a year earlier.
Analysis
Calidi Biotherapeutics (CLDI) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
For FY2025, Calidi Biotherapeutics' Shares Outstanding (Entity) was 268,875, up 544.9% from FY2024.
- Shares Outstanding (Entity) carries a four-year compound annual growth rate of 87.3% (FY2021 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 41,691 in FY2024 (+374.0%), 8,795 in FY2023 (-47.0%), 16,605 in FY2022 (-24.0%) and 21,859 in FY2021.
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q4 2021.
- The fastest year-over-year change in Shares Outstanding (Entity) over five years came in Q1 2025 (growth of 789.9%), and the weakest in Q1 2023 (a decline of 67.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Calidi Biotherapeutics | 1.50 Mn | -23.88 Mn | - | 1.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.42 Mn |
| Dec 31, 2025 | 268,875.00 |
| Sep 30, 2025 | 306,688.00 |
| Jun 30, 2025 | 179,812.00 |
| Mar 31, 2025 | 165,582.00 |
| Dec 31, 2024 | 41,691.00 |
| Sep 30, 2024 | 48,493.00 |
| Jun 30, 2024 | 27,749.00 |
| Mar 31, 2024 | 18,607.00 |
| Dec 31, 2023 | 8,795.00 |
| Sep 30, 2023 | 9,550.00 |
| Jun 30, 2023 | 9,550.00 |
| Mar 31, 2023 | 9,550.00 |
| Dec 31, 2022 | 16,605.00 |
| Sep 30, 2022 | 18,204.00 |
| Jun 30, 2022 | 29,208.00 |
| Mar 31, 2022 | 29,208.00 |
| Dec 31, 2021 | 21,859.00 |
API Access
Calidi Biotherapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CLDI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "CLDI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CLDI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();